Precision surgical systems for minimally invasive, bone conserving, orthopaedic surgery.

Venture Fund with a remit to generate commercial and social returns by investing in ventures in under-invested areas.

Real-time gas sensor offering substantially greater levels of sensitivity over existing technology. Initial markets include the emissions monitoring and homeland security.

Wound healing and skin regeneration products using active cell therapies delivered optimally using proprietary methods.

£30M fund with £20M government leverage focussed on investments in early stage sustainable technologies.

Nexeon is developing novel battery technology to enable greater energy storage.

Highly efficient and cost effective mixing technology solutions for a range of chemicals processing industries including pharmaceuticals, speciality chemicals, oils and biofuels

Leading developer of wave energy conversion devices (the Pelamis). Pelamis wave power is currently developing the world’s first commercial wavefarm in Portugal.

EDA software and intellectual property (IP) for the design of clockless Network on Chip (NoC). This approach lowers chip power consumption, reduces design complexity and accelerates time to market.

The fund invests in businesses emerging from The University of Manchester’s 5-star rated academic departments.

Official web portal bookings and information centre for Scottish National Tourist Board.

Maggot therapy, producing and supplying clinical grade maggots and derived products for use in wound debridement.

Rapid, in-field nucleic acid testing technology for clinical, veterinary and security applications.

Technology transfer services for Imperial College and other institutions and investment in spin-outs.

Fund focussed on Investments in new technologies and services for re-cycling market.

Sensor Holograms for various clinical, security and industrial applications. Cambridge University Spin-out.